Clinical Terminal
Technology

Deerfield Management, AWS partner to scale AI-native healthcare companies

Deerfield Management said on Nov. 9, 2026 that it has entered a collaboration with Amazon Web Services aimed at accelerating the development and scaling of AI-native healthcare and life sciences companies. Under the arrangement, AWS is designated a preferred AI provider for Deerfield and selected portfolio companies, according to the announcement.

By The Desk - Jordan Leahy Nov 9, 2026

Deerfield Management, AWS partner to scale AI-native healthcare companies

The collaboration combines AWS generative AI and cloud services with Deerfield Intelligence's AI engineering team and the ecosystem around Cure, Deerfield's healthcare innovation campus in New York City. Deerfield said the goal is to let selected portfolio companies deploy agentic AI systems across drug discovery, operational automation, and care delivery, with technical enablement covering large-scale model training, inference optimization, and healthcare-specific managed services.

AWS's Dan Sheeran cited services such as Amazon Bio Discovery and Amazon Bedrock AgentCore as tools portfolio companies could use to build AI agents. Deerfield Managing Partner Jim Flynn said the firm's Intelligence team is developing models intended to change how it sources opportunities, evaluates science, and accelerates portfolio companies.

Ascertain, a Deerfield-backed healthcare technology company, already uses AWS services in its agentic AI platform for clinical and administrative workflows such as case management and prior authorization. Mark Michalski, Deerfield's chief information officer and Ascertain's CEO, said the AWS services could help scale those capabilities. Deerfield and AWS also plan to co-host joint programming at Cure.